Literature DB >> 11023710

Effects of acetylbergenin against D -galactosamine-induced hepatotoxicity in rats.

H K Lim1, H S Kim, H S Choi, S Oh, C G Jang, J Choi, S H Kim, M J Chang.   

Abstract

The hepatoprotective effects of acetylbergenin were examined against D -galactosamine (GalN)-induced liver damage in rats, compared with that of bergenin reported previously. Acetylbergenin was synthesized from acetylation of bergenin, isolated from Mallotus japonicus, to increase lipophilic and physiological activities. Acetylbergenin was administered orally once daily for 7 days and then GalN (400 mg kg(-1), i.p.) was injected at 24 h and 96 h after the final administration of acetylbergenin. Acetylbergenin reduced the elevated serum enzyme activities of alanine/aspartate aminotransferase, sorbitol dehydrogenase and gamma -glutamyltransferase and the formation of hepatic malondialdehyde induced by GalN. Acetylbergenin also significantly restored towards normalization the decreased levels of glutathione and the decreased activities of glutathione S-transferase and glutathione reductase induced by GalN. Therefore, these results suggest that acetylbergenin has hepatoprotective effects against GalN-induced hepatotoxicity by inhibiting lipid peroxidation and maintaining an adequate level of GSH for the detoxification of xenobiotics as underlying hepatoprotective mechanisms. In addition, lipophilic acetylbergenin showed more activity in the hepatoprotection than that of the much less lipophilic bergenin reported previously. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023710     DOI: 10.1006/phrs.2000.0730

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Effect of Tridax procumbens on liver antioxidant defense system during lipopolysaccharide-induced hepatitis in D-galactosamine sensitised rats.

Authors:  Vilwanathan Ravikumar; Kanchi Subramanian Shivashangari; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Anti-hepatitis B virus effect and possible mechanism of action of 3,4-o-dicaffeoylquinic Acid in vitro and in vivo.

Authors:  Yi-Hang Wu; Bing-Jie Hao; Hong-Cui Cao; Wei Xu; Yong-Jun Li; Lan-Juan Li
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-03       Impact factor: 2.629

3.  Protective Properties of Laggera alata Extract and its Principle Components Against d-Galactosamine-Injured Hepatocytes.

Authors:  Yi-Hang Wu; Bing-Jie Hao; E Shen; Qing-Li Meng; Ming-Hui Hu; Yu Zhao
Journal:  Sci Pharm       Date:  2012-02-08

4.  Toxicological Assessment of Pseudospondias microcarpa (A. Rich.) Engl. Hydroethanolic Leaf Extract in Rats: Haematological, Biochemical, and Histopathological Studies.

Authors:  Donatus Wewura Adongo; Priscilla Kolibea Mante; Kennedy Kwami Edem Kukuia; Charles Kwaku Benneh; Robert Peter Biney; Eric Boakye-Gyasi; Nicholas Akinwale Titiloye; Eric Woode
Journal:  ScientificWorldJournal       Date:  2018-05-20

5.  Amelioration of galactosamine-induced nephrotoxicity by a protein isolated from the leaves of the herb, Cajanus indicus L.

Authors:  Mahua Sinha; Prasenjit Manna; Parames C Sil
Journal:  BMC Complement Altern Med       Date:  2007-04-25       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.